Interaction between mGluR5 and NMDA receptors (NMDAR) is vital for synaptic plasticity and cognition. We recently demonstrated that stimulation of mGluR5 enhances NMDAR responses in hippocampus by phosphorylating NR2B (Tyr1472) subunit, and this reaction was enabled by adenosine A 2A receptors (A 2A R) (J Neurochem, 135, 2015, 714). In this study, by using in vitro phosphorylation and western blot analysis in hippocampal slices of male Wistar rats, we show that mGluR5 stimulation or mGluR5/NMDARs co-stimulation synergistically activate ERK1/2 signaling leading to c-Fos expression. Interestingly, both reactions are under the permissive control of endogenous adenosine acting through A 2A Rs. Moreover, mGluR5-mediated ERK1/2 phosphorylation depends on NMDAR, which however exhibits a metabotropic way of function, since no ion influx through its ion channel is required. Furthermore, our results demonstrate that mGluR5 and mGluR5/NMDAR-evoked ERK1/2 activation correlates well with the mGluR5/NMDAR-evoked NR2B (Tyr1472) phosphorylation, since both phenomena coincide temporally, are Src dependent, and are both enabled by A 2A Rs. This indicates a functional involvement of NR2B(Tyr1472) phosphorylation in the ERK1/2 activation. Our biochemical results are supported by electrophysiological data showing that in CA1 region of hippocampus, the theta burst stimulation (TBS)-induced long-term potentiation coincides temporally with an increase in ERK1/2 activation and both phenomena are dependent on the tripartite A 2A , mGlu5, and NMDARs. Furthermore, we show that the dopamine D1 receptors evoked ERK1/2 activation as well as the NR2B(Tyr1472) phosphorylation are also regulated by endogenous adenosine and A 2A Rs. In conclusion, our results highlight the A 2A Rs as a crucial regulator not only for NMDAR responses, but also for regulating ERK1/2 signaling and its downstream pathways, leading to gene expression, synaptic plasticity, and memory consolidation. Metabotropic glutamate receptor 5 (mGluR5) is a subtype of the group I mGlu receptors that belongs, as the other mGluR subtypes, to the C class of G-protein-coupled receptors family (Niswender and Conn 2010). MGlu5 receptors are mainly localized on postsynaptic elements and seem to be widely distributed in corticolimbic areas that control higher cognitive and incentive functions in the brain, such as hippocampus and prefrontal cortex (Romano et al. 1995) . Due to this specific localization, mGluR5s appear to play a key role in the regulation of various cognitive functions, such as learning and memory, and in distinct forms of synaptic plasticity, including long-term potentiation (LTP) and long-term depression (Jia et al. Received July 19, 2017; revised manuscript received October 11, 2017; November 20, 2017; accepted November 24, 2017. Address correspondence and reprint requests to Dr Fevronia Angelatou and Dr Konstantinos Sarantis, Department of Physiology, School of Medicine, University of Patras, 26500, Patras, Greece. E-mails: rangel@med.upatras.gr and konsaran@yahoo.gr 1 These authors contributed equally to this work. 2 Co-senior authors.
Metabotropic glutamate receptor 5 (mGluR5) is a subtype of the group I mGlu receptors that belongs, as the other mGluR subtypes, to the C class of G-protein-coupled receptors family (Niswender and Conn 2010) . MGlu5 receptors are mainly localized on postsynaptic elements and seem to be widely distributed in corticolimbic areas that control higher cognitive and incentive functions in the brain, such as hippocampus and prefrontal cortex (Romano et al. 1995) . Due to this specific localization, mGluR5s appear to play a key role in the regulation of various cognitive functions, such as learning and memory, and in distinct forms of synaptic plasticity, including long-term potentiation (LTP) and long-term depression (Jia et al. 2001; Simonyi et al. 2005 Simonyi et al. , 2010 Sheffler et al. 2011; Purgert et al. 2014) .
The role of mGlu5 receptor in synaptic plasticity may be mediated, at least in part, by its regulation of molecular mechanisms such as phosphorylation of extracellular signalregulated protein kinase (ERK) 1/2 in hippocampus and prefrontal cortex (Berkeley and Levey 2003; Liu et al. 2006 Liu et al. , 2008 Mao et al. 2008) . Phosphorylation of ERK1/2 on Thr202/Tyr204 leads to the activation of this kinase to mediate an array of various signaling pathways that control neuronal plasticity (Thomas and Huganir 2004) . It also plays a key role in the transcriptional control of immediate-early genes expression, such as c-Fos and zif-268, both being crucial for neuronal plasticity and memory processes (Thomas and Huganir 2004; Minatohara et al. 2015) .
Many electrophysiological studies determined that mGluR5s are involved in the potentiation of N-methyl-Daspartate (NMDA)-induced currents and in the enhancement of NMDA receptor (NMDAR)-dependent LTP in the hippocampus (Doherty et al. 1997; Kotecha et al. 2003; Rosenbrock et al. 2010; Chen et al. 2011) . In 2004, Yang et al. examined in the striatum the interaction between NMDARs and mGluR5s and had identified a Ca 2+ -independent synergistic effect of co-activation of these two receptors on ERK1/2 phosphorylation. This synergistic effect seems to rely on a cross talk between NMDAR-associated synaptic adaptor protein PSD-95 and the mGluR5-linked adaptor protein Homer1b/c (Yang et al. 2004) . Until now, there are no biochemical studies to determine the exact interaction of mGlu5 and NMDARs and its effect on ERK1/2 activation in hippocampus.
Adenosine is an endogenous purine nucleoside that modulates dopamine and glutamate signaling by activating four G-protein-coupled receptor types: A 1 , A 2A , A 2B , and A 3 (Fredholm et al. 2011; Cunha 2008 Cunha , 2016 . A functional interaction between A 2A R and mGluR5 has been recently reported in the hippocampus, where A 2A Rs and mGluR5s are co-localized and synergistically interact to modulate NMDAR-mediated effects (Rebola et al. , 2008 Tebano et al. 2005 Tebano et al. , 2006 .
A previous study of our laboratory (Sarantis et al. 2015) showed that in hippocampus, adenosine A 2A receptors have also a permissive role on the mGluR5-evoked phosphorylation of NR2B subunit of NMDAR at Tyr1472 site. The main role of this NR2B(Tyr1472) phosphorylation is to anchor NR2B-containing NMDARs to the surface of post-synaptic membranes, preventing their internalization (Prybylowski et al. 2005; Lee 2006; Chen and Roche 2007; Lau and Zukin 2007) , thus, enhancing NMDAR-dependent currents (Sarantis et al. 2015) .
Functional interactions between dopamine D1 and NMDARs have also been shown to play a critical role in attention, working memory (Missale et al. 2006) , and spatial novelty detection (Sarantis et al. 2012) . We have previously shown that dopamine D1 receptors (D1R) and NMDAR interactions are required for ERK1/2 activation and subsequent increase of c-Fos expression, following exposure to a novel environment (Sarantis et al. 2009 (Sarantis et al. , 2012 . In addition, a recent study (David et al. 2014) showed that activation of D1R induces both the NR2B(Tyr1472) phosphorylation and ERK1/2 activation.
Taking all the above into consideration, the aim of this study was to investigate the molecular mechanism in the hippocampus by which the interaction of mGlu5 and NMDARs affects the ERK1/2 activation, and the possible role of adenosine A 2A Rs on this interaction. We further examined the involvement of A 2A Rs on the mGluR5-and D1R-mediated ERK1/2 activation and NR2B(Tyr1472) phosphorylation. Using electrophysiological techniques, we have investigated in the hippocampal cornu ammonis area 1 (CA1) minislices the possible correlation between ERK1/2 activation and induction of LTP under physiological conditions and under pharmacological blockage of mGlu5, NMDA, and A 2A receptors.
Materials and methods
This study was not pre-registered.
Animals and slice preparation
Adult male Wistar rats (RRID: RGD2308816), 2-6 months old, weighing 200-300 g, originally raised in the Animal Facility of the Medical School of the University of Patras, were used. All experimental treatment and procedures were conducted according to the European Communities Council Directive Guidelines (86/ 609/EEC, JL 358, 1, December, 12, 1987) for the care and use of laboratory animals, and they have been approved by the Prefectural Animal Care and Use Committee (No: EL 13BIO04). In addition, all efforts were made to minimize the number of animals we have used. More specifically, we have used the statistical power analysis program G*power 3.1.9.2 to a priori compute the required number of animals. Animals were housed under controlled conditions of temperature (20-22°C), light-dark cycle (12-12 h), and free access to food and water. For each experiment the animals were selected randomly according to the simple randomization method (Suresh 2011) . In order to avoid any suffering of the animals, they were decapitated after deep anesthesia with diethyl ether. The brain was removed and placed in chilled (2-4°C) standard artificial cerebrospinal fluid containing 124 mM NaCl, 4 mM KCl, 2 mM MgSO 4 , 2 mM CaCl 2 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , and 10 mM glucose, equilibrated with 95% O 2 and 5% CO 2 gas mixture at pH = 7.4. Then, the hippocampi were excised free and transverse slices 350 lm thick (for neurochemical experiments) or 550 lm thick (for electrophysiological experiments) were prepared from the dorsal part of hippocampus using a McIlwain tissue chopper. No blinding was applied for any of the experimental procedures used.
In vitro stimulation of mGlu5/NMDARs under pharmacological manipulation Hippocampal slices were incubated in artificial cerebrospinal fluid solution (AE35°C) and oxygenated constantly with 95% O 2 -5% CO 2 for at least 60 min before drug application. The slices were classed in the following drug combinations: The drugs were applied for 5 min for the detection of ERK1/2 phosphorylation and for 30 min for the detection of c-Fos expression. The slices were instantly frozen in isopentane (À50°C) and stored at À80°C until use. In experiments performed in the presence of selective inhibitor of the Src family tyrosine kinases, PP1 (30 lM) (Hanke et al. 1996; Rebola et al. 2008) , the selective antagonist of A 2A adenosine receptors, ZM241385 (1 lM) (Cunha et al. 1997; Rebola et al. 2008) , the ADA (10 lg/ mL) (Dell'anno et al. 2013) , the DL-2-amino-5-phosphonovaleric acid (AP5) (100 lΜ) (Yang et al. 2004; David et al. 2014) , and the (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d]cyclohepten-5,10-imine maleate (MK801) (100 lΜ) (Yang et al. 2004) , the PP1, ZM241385, ADA, AP5, and MK801 were applied 30 min prior to the incubation of slices with the drug combinations.
Western blotting
The experiments were carried out as described previously (Brooks-Kayal et al. 2001) . Briefly, the slices were rapidly homogenized and then solubilized in 100 lL 1% v/w sodium dodecyl sulfate with 4 lL Sigma phosphatase inhibitor cocktail I, 4 lL Sigma phosphatase inhibitor cocktail II, and 4 lL Sigma protease inhibitor cocktail, sonicated, and then boiled for 10 min. The protein concentration was determined for each sample by using the NanoDrop 2000 Spectophotometer (Thermo Scientific, Waltham, MA, USA). Duplicated samples (50 lg of total protein) were separated on 12% or 7% polyacrylamide gel and then transferred to nitrocellulose. After 1 h of blocking in 10% nonfat dried milk at 21°C, the nitrocellulose was incubated at 4°C overnight with the following antibodies: rabbit anti-PhosphoERK1/2 (Thr202/Tyr204) polyclonal antibody (1 : 6000, Cell Signaling Technology, Beverly, MA, USA, RRID:AB_331772), mouse anti-c-Fos polyclonal antibody (1 : 250, Santa Cruz, RRID:AB_627253), and rabbit anti-phospho-NMDAR2B (Tyr1472) polyclonal antibody (1 : 500, Cell Signaling Technology, RRID:AB_1549657). The total amount of protein was detected using rabbit anti-ERK1/2 monoclonal antibody (1 : 1000, Cell Signaling Technology, RRID:AB_330744) and rabbit anti-NMDAR2B (1 : 1000, Cell Signaling Technology, RRID: AB_1264223) monoclonal antibody diluted in 10% nonfat dried milk. The blot was rinsed with Tris-buffered saline -Tween and then incubated with goat anti-rabbit horseradish peroxidase-linked IgG or goat anti-mouse horseradish peroxidase-linked IgG for 1 h at 21°C, followed by the enhanced chemiluminescence detection system (Millipore Corporation, Bedford, MA, USA). The analysis of total protein levels was performed on the same blots after stripping of the nitrocellulose, since the same secondary antibodies were used for the phosphorylated and the total levels of the proteins. The nitrocellulose was stripped using mild stripping protocol by Abcam (Cambridge, UK). Molecular masses were determined by comparison with prestained protein molecular weight marker standards from Biomol (Biomol GmbH, Hamburg, Germany). The blots were reprobed with anti-tubulin mouse monoclonal antibody (1 : 80.000; T5168; Sigma), rinsed with Tris-buffered saline-Tween, and then incubated with anti-mouse antibody and normalized to verify equivalent protein loading. Luminescence from the blots was detected by exposing the membranes to Fuji-Hyperfilm for 30 s to 7 min, in order to ensure that we were operating within the linear range of the film, followed by digital scanning of the developed film in transparency mode. The scanned image of the membranes and band intensities were calibrated and quantified using NIH ImageJ software (version 1.48) (National Institutes of Health, Bethesda, MD, USA). For each situation, the values obtained from the experiments with phosphorylated and total ERK1/2 corresponded to the total of the bands intensities for both ERK1 and ERK2 (also called p44 and p42 MAP kinases, in relation to their molecular weights, 44 and 42 kDa, respectively). For each situation, the values of the phosphorylated levels of each protein examined were normalized with the respective total levels. Each experiment was performed three to seven times.
Electrophysiological experiments
Immediately after their preparation, hippocampal slices were placed in an interface-type recording chamber. The CA1 field was isolated from the other hippocampal subfield making three knife cuts in the slices: at the Schaffer collaterals, at the level of the hippocampal fissure, and at the CA1-subiculum border. The so-prepared CA1 minislices were allowed to equilibrate for at least 1 h before starting recordings. Electrophysiological recordings of field excitatory postsynaptic potentials (fEPSPs) were made from the stratum radiatum of the CA1 field following electrical stimulation of the Schaffer collaterals using a carbon fiber of 7 lm diameter (Kation Scientific, Minneapolis, MN, USA). Baseline electrical stimulation was delivered every 30 s using a bipolar platinum/iridium electrode (25 lm wire diameter, at an inter-wire distance of 100 lm, World Precision Instruments, Sarasota, FL, USA). The amplitude of electrical pulses varied from 20 to 250 lA, and they had a fixed duration of 100 ls. The strength of stimulation was set to evoke half-maximum fEPSP. Stimulation and recording electrodes were placed at a distance of about 350 lm from each other. Only slices which displayed stable fEPSP for at least 10 min were selected for further experimentation. Signals were acquired with a Neurolog amplifier (Digitimer Limited, UK), band-pass filtered at 0.5-2 kHz, digitized at 10 kHz, and stored on a computer disk using the Cambridge Electronic Design (CED) 1401-plus interface and the Signal software (Cambridge Electronic Design, Cambridge, UK) for offline analysis. LTP was induced by delivering theta burst stimulation (TBS) at the Schaffer collaterals. TBS consisted of three trains of 10 bursts delivered at the frequency of 5 Hz with inter-train intervals of 30 s. Each burst consisted of four pulses at 100 Hz. fEPSP was quantified by the maximum slope (mV/ms) of its initial rising phase measured in a time frame of 1 ms immediately following the appearance of the negativity attributed to presynaptic fiber volley.
Statistics
The statistical analysis of all experiments was performed by the IBM SPSS V21.0 software (IBM Corporation, Armonk, New York, USA). For the western blotting experiments, statistical analysis used ANOVA followed by Tukey and Least Significant Difference (LSD) post hoc tests. The values of the various parameters are expressed as means AE SEM values (number of animals, N = 4-10) per group of representative western blots. For the electrophysiological experiments, the nonparametric Wilcoxon test and Mann-Whitney U test were used for comparisons between related and independent two groups of values, respectively. The values of the various parameters are expressed as mean AE SEM and 'n' throughout the text indicates the number of slices used in the analysis.
Results
Glutamate mGlu5 receptors promote ERK1/2 phosphorylation in dorsal hippocampal slices in a dosedependent manner In our previous work (Sarantis et al. 2015) , we have shown that mGluR5 activation, as well as co-activation of mGluR5 and NMDARs, induces a robust phosphorylation of NR2B subunit of NMDAR at Tyr1472, which plays a pivotal role in NMDAR internalization. Herein, we wanted to investigate whether mGluR5 stimulation or mGluR5/NMDAR costimulation has any effect on ERK1/2 phosphorylation in dorsal hippocampus.
Our data showed that in vitro incubation of hipppocampal slices with the selective agonist of mGluR5, CHPG induced a dose-dependent increase in the phosphorylation level of ERK1/2 (18% by 30 lM, however not significant, and 32% by 50 lM CHPG) compared to basal levels (Fig. 1a) . More specifically, 50 lΜ CHPG brought the phosphorylation state at a plateau level, showing no further remarkable increase by either 100 lM or 300 lΜ CHPG. However, using 500 lΜ CHPG, the phosphorylation state increased significantly further (Fig. 1a) .
To evaluate the time course of the p-ERK1/2 induction, dorsal hippocampal slices were incubated with CHPG (50 lΜ) for different time durations, ranging from 1 to 20 min. As shown in Fig. 1b , the CHPG-evoked ERK1/2 phosphorylation was rapid and transient, occurring between the 3rd and the 6th minute of drug incubation, showing a maximum state at the 5th min.
Synergistic interaction between mGluR5 and NMDARs on ERK1/2 phosphorylation Our results showed that in vitro incubation of hippocampal slices with the mGluR5-selective agonist CHPG at the concentration of 15 lΜ failed to increase the phosphorylation level of the ERK1/2 compared to control levels ( Fig. 2a) . The same result was observed when the hippocampal slices were incubated only with NMDA, the selective agonist of the NMDARs, at the concentration of 5 lΜ. Interestingly, the co-incubation of hippocampal slices with the ineffective doses of the mGluR5 agonist CHPG (15 lΜ) and NMDAR-selective agonist, NMDA (5 lΜ), induced a robust increase in the phosphorylation state of ERK1/2 compared to basal levels ( Fig. 2a) , reaching the plateau levels seen before by using 50 lM CHPG (Fig. 2a) . This indicates a strong synergy between mGluR5 and NMDAR on ERK1/2 activation.
It is known that in hippocampus and other brain regions, cFos expression is mediated by ERK1/2-induced phosphorylation of nuclear transcription factors like ETS Like Kinase 1 (ELK1) and cyclic AMP-responsive element-binding protein, which binds on the c-Fos promoter (Valjent et al. 2001) . To examine whether the mGluR5-and the mGluR5/NMDARinduced ERK1/2 phosphorylation is associated with gene activation, we investigated whether c-Fos expression is affected by the application of CHPG (50 lΜ) and the coapplication of CHPG (15 lΜ) and the NMDA (5 lΜ) in hippocampal slices. Incubation with the above pharmacological combinations lasting for 30 min showed that both the mGluR5-and the mGluR5/NMDAR-mediated activation of ERK1/2 is sufficient to induce increased c-Fos protein expression (Fig. 2b) .
Phosphorylation of ERK1/2 by mGluR5 activation is NMDAR dependent To clarify the exact interaction between mGluR5s and NMDARs and its subsequent impact on ERK1/2 phosphorylation, we further investigated whether the NMDARs are required for the mGluR5-induced phosphorylation of ERK1/2. In vitro incubation of the dorsal hippocampal slices with the selective antagonist of NMDAR, AP5 (100 lΜ) alone did not alter the basal pERK1/2 levels. In addition, the simultaneous incubation of hippocampal slices with the combination of CHPG (15 lM) and NMDA (5 lΜ) in the presence of AP5 (100 lM) prevented, as expected, the mGluR5/NMDAinduced increase in phosphorylation of ERK1/2. Interestingly, the co-application of CHPG (50 lΜ) with AP5 completely abolished the CHPG-induced phosphorylation of ERK1/2, indicating that NMDARs are required for the mGluR5-evoked phosphorylation of ERK1/2 (Fig. 3a) .
In contrast to the effect of AP5, the channel blocker of NMDAR, MK801 (100 lΜ), had no effect on mGluR5-and mGluR5/NMDAR-induced ERK1/2 phosphorylation. More specifically the simultaneous incubation of hippocampal slices with the CHPG (50 lΜ) or the combination of CHPG (15 lM) and NMDA (5 lΜ) in the presence of ΜΚ801 (100 lM) did not alter either the mGluR5-or the mGluR5/ NMDAR-induced phosphorylation of ERK1/2 (Fig. 3b) . This indicates that the above reaction does not require the Ca 2+ influx through NMDAR channel. To further investigate the pathway of this mGluR5-and mGluR5/NMDA-mediated ERK1/2 phosphorylation, we examined the possible involvement of Src family kinases to this phosphorylation. Incubation of dorsal hippocampal slices with the selective inhibitor of Src family kinases, PP1 (30 lΜ), completely abolished the CHPG-induced ERK1/2 phosphorylation (Fig. 3c) . Similarly, co-incubation of hippocampal slices with the combination of CHPG (15 lΜ) and NMDA (5 lΜ) in the presence of PP1, down-regulated the CHPG/NMDA-induced ERK1/2 phosphorylation to basal levels (Fig. 3c) . The above results indicate that Src kinases are involved in the mGluR5-and the mGluR5/NMDARmediated ERK1/2 phosphorylation.
Involvement of adenosine A 2A receptors in the mGluR5-and mGluR5/NMDA-evoked ERK1/2 phosphorylation in dorsal hippocampus It has been demonstrated that adenosine A 2A and mGluR5 are co-localized and functionally interact in hippocampus (Tebano et al. 2005) . Furthermore, according to our recent results (Sarantis et al. 2015) , A 2A receptors seem to permit the mGluR5-and mGluR5/NMDAR-evoked phosphorylation of NR2B subunit of NMDAR at Tyr1472. Taken the above into consideration, it was of interest to investigate the role of adenosine A 2A Rs in the mGluR5-induced phosphorylation of ERK1/2. For this reason, we co-incubated dorsal hippocampal slices with CHPG in the presence of the selective antagonist of adenosine A 2A receptors, ZM241385. We found that incubation of the slices with only ZM241385 (1 lΜ) did not alter the basal levels of pERK1/2, but the coincubation of hippocampal slices with 1 lΜ ZM241385 and 50 lΜ CHPG completely abolished the CHPG-induced phosphorylation of ERK1/2. Similar results were obtained when we co-incubated hippocampal slices with the combination of 15 lΜ CHPG and 5 lM NMDA in the presence of 1 lM ZM241385. ZM241385 totally abolished the CHPG/ NMDA-induced ERK1/2 phosphorylation, indicating that adenosine A 2A receptors enable this phosphorylation (Fig. 4a) .
In order to further investigate the involvement of A 2A receptors in the CHPG-induced phosphorylation of ERK1/2, we examined the effect of the mGluR5 stimulation on pERK1/ 2 levels under enzymatic degradation of endogenous adenosine, achieved by using the adenosine deaminase, ADA. Our results showed that in vitro co-incubation of hippocampal slices with 50 lΜ CHPG in the presence of 10 lg/mL ADA down-regulated the CHPG-induced ERK1/2 phosphorylation to basal levels (Fig. 4b) . Interestingly, co-administration of the selective agonist of adenosine A 2A receptors, CGS21680 (30 nM), in the above drug combination (CHPG/ADA), induced a robust increase in the pERK1/2 levels similar to that evoked by CHPG (50 lΜ) (Fig. 4b) . The above results indicate a permissive role of adenosine A 2A receptors on the mGluR5-mediated effects on ERK1/2 phosphorylation. Is there any correlation between mGluR5-mediated NR2B (Tyr1472) phosphorylation and ERK1/2 activation? Recent results by David et al. (2014) suggest that the dopamine D1 receptor-evoked NR2B phosphorylation at Tyr1472 not only correlates well with the D1R-evoked ERK1/2 activation, but it is also necessary for it.
Herein, we present a pharmacological profile in which the effect of different drugs on ERK1/2 activation is in coincidence with the NR2B(Tyr1472) phosphorylation ( Fig. 5a and b) . As it is indicated in Fig. 5b , stimulation of mGluR5 or co-stimulation of mGluR5 and NMDARs with ineffective doses of their agonists (when given alone) induces a robust increase in NR2B(Tyr1472) phosphorylation, which coincides well with a significant increase in pERK1/2 levels (Fig. 5a ). In addition, both phenomena, that is, NR2B phosphorylation and ERK1/2 activation, seem to be regulated by A 2A receptors, since in the presence of ZM241385 (A 2A Rs antagonist), the mGluR5-evoked NR2B (Tyr1472) phosphorylation and the ERK1/2 activation are totally abolished. Furthermore, in both phenomena Src kinases seem to be involved, since in the presence of PP1 (Src inhibitor), the phosphorylation of NR2B(Tyr1472) is drastically down-regulated simultaneously with the abolishment of ERK1/2 phosphorylation.
However, there is a significant discrepancy between the two phenomena, that is, between the NR2B(Tyr1472) phosphorylation and ERK1/2 activation. As it is shown in Fig. 3a, mGluR5 receptor stimulation induces ERK1/2 activation in an NMDAR-dependent manner. To investigate whether the NMDARs are also required for the mGluR5-evoked phosphorylation of NR2B(Tyr1472), we co-incubated dorsal hippocampal slices with 50 lΜ CHPG and the NMDAR antagonist, AP5 (100 lΜ). Our results showed that blockage of the NMDAR with 100 lΜ AP5 did not affect the CHPG-induced NR2B(Tyr1472) phosphorylation (Fig. 5b) . The above results indicate that the mGluR5-mediated NR2B (Tyr1472) phosphorylation is NMDAR independent unlike the evoked phosphorylation of ERK1/2.
Permissive role of adenosine A 2A receptors in both D1R-induced phosphorylation of NR2B(Tyr 1472) and of ERK1/2 in dorsal hippocampus Our results showed that in vitro stimulation of dopamine D1 receptors in hippocampal slices with their selective agonist, SKF38393 (20 lΜ), significantly increased the phosphorylation state of NR2B subunit of NMDAR at Tyr1472. This increase coincides well with a significant enhancement of ERK1/2 phosphorylation levels ( Fig. 6a  and b) . These results are in accordance with those of David et al. (2014) .
We next examined whether this D1R-mediated phosphorylation of NR2B(Tyr1472) and ERK1/2 involves the adenosine A 2A receptors as it happens in the mGluR5-evoked phosphorylation shown above. For this reason, we with ZM241385 significantly reduced the D1R-mediated phosphorylation of NR2B(Tyr 1472) (Fig. 6b) , and more importantly, inhibited the increase of ERK1/2 activation (Fig. 6a) .
There was also a total abolishment of the D1R-induced phosphorylation of NR2B(Tyr1472) and ERK1/2 after enzymatic degradation of endogenous adenosine, achieved with the addition of adenosine deaminase, ADA(10 lg/mL). However, when the selective agonist of adenosine A 2A receptor, CGS21680 (30 nM), was added in the drug combination of SKF/ADA, a remarkable increase in the phosphorylation levels of both NR2B(Tyr1472) and ERK1/2 was observed, similar to that evoked by SKF38393 (20 lM) (Fig. 6a and b) . These results indicate that A 2A receptors in addition to mGluR5-evoked phosphorylation also modulate the D1R-mediated NR2B(Tyr1472) and ERK1/2 phosphorylation.
Correlation of TBS-induced LTP and ERK1/2 activation in CA1 minislices
Recordings of fEPSP were made in dorsal hippocampal slices in which the CA3 field was removed (CA1 minislices). LTP was induced in these slices by delivery of TBS at the Schaffer collaterals. As shown in In order to investigate the possible correlation of the TBSinduced LTP, which implicates NMDA, mGlu5, and A 2A adenosine receptors, with the activation of ERK1/2, we examined the phosphorylation levels of ERK1/2 at the above CA1 minislices. Our results showed that in CA1 minislices collected 5 min after the TBS delivery, the phosphorylation levels of ERK1/2 were similar to basal ones (Fig. 8b) . However, the minislices collected 1 h after the TBS delivery, in which a high-magnitude LTP was induced (Fig. 8a) , a remarkable increase of ERK1/2 phosphorylation was detected (Fig. 8b) . On the other hand, the minislices collected 1 h after the TBS delivery, which were incubated with the antagonists of NMDA, mGlu5, and A 2A receptors (AP5, MPEP, and ZM241385 respectively), showed a total abolishment of the TBS-induced ERK1/2 phosphorylation, which coincides well with the LTP reduction (Fig. 8b) .
Discussion
In the present study, we have shown for the first time that concomitant stimulation of mGluR5 and NMDARs synergistically up-regulate ERK1/2 phosphorylation in rat hippocampus, and this ERK1/2 activation is under the permissive control of adenosine A 2A receptors. In parallel, stimulation of mGluR5 alone with its selective agonist also increased ERK1/2 activation, which was NMDA dependent, and is also enabled by A 2A receptors. According to our results, the mGluR5 as well as the mGluR5/NMDARs mediated ERK1/2 activation correlate well with the evoked NR2B(Tyr1472) phosphorylation, since both phenomena are induced in temporal coincidence by the same receptor stimulation (Sarantis et al. 2015) , are Src kinases dependent, and are both permitted by endogenous adenosine through the A 2A receptors. The electrophysiological data using CA1 minislices have shown a tight correlation between TBSinduced LTP and ERK1/2 phosphorylation, both phenomena (100 nM) (38.3 AE 2.5%, n = 12 slices, Wilcoxon test, p < 0.005) was significantly lower compared with control (MannWhitney U test, p < 0.001). Similarly, blockade of mGluR5 by 200 lΜ MTEP induced LTP (31.6 AE 3.0%, n = 13 slices, Wilcoxon test, p < 0.005) of significantly smaller magnitude than in control conditions (Mann-Whitney U test, p < 0.001; Fig. 8 ). Blockade of NMDA receptors by 50 lΜ AP5 produced a strong reduction in the magnitude of LTP, but did not prevent its induction. Specifically, the percentage increase of fEPSP was 10.0 AE 2.8% (n = 6 slices, Wilcoxon test, p < 0.05) and it was significantly lower than under blockade of either A 2A Rs or mGluR5 (Mann-Whitney U test, p < 0.05). The horizontal bar indicates the last 15 min of drug application. Examples of fEPSP waveforms before and 60 min after the delivery of TBS (thin and thick lines, respectively) are shown on the top of the graph. Calibration bars: 1 mV and 5 ms.
coinciding temporally and both depending on the tripartite A 2A , mGluR5, and NMDARs. Our results further demonstrated that stimulation of dopamine D1 receptors in hippocampal slices also induces a significant increase in both ERK1/2 activation and NR2B(Tyr1472) phosphorylation, confirming the data of David et al. (2014) . Moreover we have shown for the first time that the D1R-mediated ERK1/2 activation and NR2B(Tyr1472) phosphorylation occur under the permissive control of A 2A receptors. Taken together, our results highlight the role of adenosine A 2A receptor in hippocampus, which is revealed as a crucial regulator of glutamate mGlu5 and dopamine D1 receptormediated effects on NMDAR actions, but also on ERK1/2 signaling pathway and on TBS-induced LTP.
Our results demonstrated that stimulation of mGluR5s in hippocampal slices with their selective agonist CHPG evokes a dose-dependent ERK1/2 phosphorylation, which reaches a plateau level at 50 lM. This ERK1/2 activation is a rapid and transient phenomenon lasting 3-5 min similar to the mGluR5-evoked NR2B phosphorylation at Tyr1472 (Sarantis et al. 2015) . Interestingly, mGluR5-mediated ERK1/2 phosphorylation seems to be NMDAR dependent, since blockade of NMDAR by its selective antagonist AP5 totally abolished the evoked ERK1/2 activation. This is consistent with the results reported by David et al. (2014) , concerning the D1R-mediated ERK1/2 activation, which is also NMDAR sensitive. However, in our study, NMDAR involvement in mGluR5-mediated ERK1/2 activation does not seem to rely on Ca 2+ influx through NMDAR ion channel since the presence of MK801 (NMDAR channel blocker) had no effect on the mGluR5-evoked ERK1/2 activation. Accordingly, activation of NMDAR by endogenous glutamate or exogenous NMDA is necessary for ERK1/2 phosphorylation, but no ionic current through NMDAR channel is required, suggesting a metabotropic function of NMDAR (Dore et al. 2016) .
Similarly, co-activation of mGluR5 and NMDAR with low ineffective doses of their agonists, synergistically induced a robust up-regulation of ERK1/2 phosphorylation, which coincides well with the mGluR5/NMDAR-induced NR2B (Tyr1472) phosphorylation. Interestingly, again the presence of MK801 did not affect the synergistic effect on ERK1/2 activation. This indicates that no Ca 2+ influx through the NMDAR is necessary for the mGluR5/NMDAR synergy, supporting even stronger the notion for a metabotropic action of NMDAR, as has been described for the induction of longterm depression and excitotoxicity Nabavi et al. 2013; Dore et al. 2016; Weilinger et al. 2016) . In hippocampus, we do not know the molecular mechanism by which this interplay between mGluR5 and NMDAR converge to activate ERK1/2 signaling. However, given the absence of MK801 effect, the mechanism could be similar to that described in striatum involving an interplay between scaffolding molecules (Yang et al. 2004 ). This possible Asterisks on the top of horizontal bars indicate significant differences between experimental conditions **p < 0.01 and ***p < 0.0001. Statistical analysis used ANOVA followed by Tukey post hoc test.
interaction requires further investigation. It is, however, notable that the mGluR5/NMDAR-induced ERK1/2 activation in the hippocampus is sufficient to stimulate downstream pathways and evoke transcriptional activity, leading to early gene expression like the c-Fos, as demonstrated in the present study.
Our data have shown that mGluR5 and mGluR5/NMDAinduced ERK1/2 phosphorylation is Src kinase dependent since the co-incubation with PP1 (Src inhibitor) totally abolished the evoked ERK1/2 activation. In parallel, inhibition of Src kinases leads also to total abolishment of mGluR5 and mGluR5/NMDA-induced NR2B(Tyr1472) phosphorylation. It is well known that the NR2B subunit is phosphorylated at Tyr1472 by the Fyn kinases (member of Src tyrosine kinases) (Nakazawa et al. 2001; Takasu et al. 2002; Chen and Roche 2007) . Thus, as expected, in the presence of PP1, the evoked NR2B(Tyr1472) phosphorylation is totally abolished. The fact that in coincidence with the above, we also observe a concomitant abolishment of the evoked ERK1/2 activation, which strongly suggests that the mGluR5 and mGluR5/NMDA-evoked NR2B(Tyr1472) phosphorylation is functionally involved in the evoked ERK1/2 activation. This is in line with the results of David et al. (2014) , showing the involvement of Src kinases on both D1R-mediated NR2B(Tyr1472) phosphorylation and ERK1/2 activation.
Interestingly, blockade of adenosine A 2A receptors by their selective antagonist ZM241385 totally inhibited both the mGluR5 and the mGluR5/NMDAR-mediated ERK1/2 activation. The permissive control of A 2A receptors on ERK1/2 activation seems to be exerted through the endogenous adenosine since its degradation by adenosine deaminase totally abolished the mGluR5 and the mGluR5/NMDARinduced ERK1/2 phosphorylation. Since mGluR5 and mGluR5/NMDAR-mediated ERK1/2 activation is efficient to stimulate downstream pathways leading to transcriptional activity as the expression of c-Fos seen here, it is obvious that A 2A receptors regulate gene transcription in rat hippocampus by enabling ERK1/2 activation. However, as it has been recently shown, direct activation of A 2A R in hippocampus does not recruit phospho ERK1/2, but leads to cyclic AMP-responsive element-binding protein phosphorylation and c-Fos expression (Li et al. 2015) .
As we have shown in our recent study (Sarantis et al. 2015) , A 2A Rs exert in a similar way a permissive control on mGluR5 and mGluR5/NMDAR-mediated NR2B(Tyr1472) phosphorylation. In the same study, we have noted that in rat hippocampus a tripartite interplay of A 2A /mGluR5/NMDA receptors acts synergistically to induce NR2B(Tyr1472) phosphorylation, which seems to be (at least in part) the molecular mechanism underlying the mGluR5-evoked potentiation of NMDAR responses (Sarantis et al. 2015) . In the present study, our results revealed a tight correlation between mGluR5 and mGluR5/NMDAR-mediated ERK1/2 activation and the induced NR2B(Tyr1472) phosphorylation since the two phenomena: (i) coincide temporally (they both appear between 3 and 5 min after receptor stimulation), (ii) are both Src dependent as they are both abolished by PP1, and (iii) are both under the permissive control of endogenous adenosine acting through the A 2A receptors. In line with our results, David et al. (2014) , using NR2B F1472 mice in which the phosphorylation of NR2B at Tyr1472 does not appear, showed that stimulation of D1 receptors was unable to induce ERK1/2 activation. This indicates that NR2B(Tyr 1472) phosphorylation does not only correlate well with the D1 evoked ERK1/2 activation, but it is also necessary for it (David et al. 2014 ).We do not know the mechanism by which NR2B(Tyr1472) phosphorylation could be involved in the process of ERK1/2 activation. What it is well known is that NR2B(Tyr1472) phosphorylation anchors NR2B-containing NMDARs in the plasma membrane inhibiting their internalization (Prybylowski et al. 2005; Lee 2006; Chen and Roche 2007; Lau and Zukin 2007) , thus, enhancing NMDAR currents (Sarantis et al. 2015) . Since ERK1/2 activation demands the convergence of mGluR5 and NMDARs signaling pathways, the enrichment of NR2B-containing NMDARs in the synaptic membrane could enable the interplay between the two receptor subtypes on activating ERK1/2. However, this interplay between the two receptor subtypes does not seem to be enabled by increased Ca 2+ influx, since, as mentioned above, the presence of MK801 does not affect the synergistic induction of ERK1/2 phosphorylation. It is notable that AP5 had no effect on this mGluR5-evoked NR2B(Tyr1472) phosphorylation, which is in line with the results of David et al. (2014) reporting that D1R-evoked NR2B(1472) phosphorylation is also unaffected by AP5.
As stimulation of D1R in rat hippocampus has been reported to induce both ERK1/2 activation and NR2B (Tyr1472) phosphorylation (David et al. 2014) , it was of interest to examine if these D1R-mediated actions were also under A 2A Rs permissive control. Our experiments revealed, as expected, that stimulation of the dopamine D1 receptor by its selective agonist SKF38393 significantly enhanced both ERK1/2 activation and NR2B(Tyr1472) phosphorylation. In both cases, the blockade of A 2A receptors or degradation of endogenous adenosine totally prevented the induced enhancements, indicating that the D1R-induced phosphorylations are also permitted by endogenous adenosine acting through A 2A receptors.
In the hippocampus, the relationship between adenosine A 2A Rs with dopamine D1 receptors is not well characterized so far. In the brain, dopamine and adenosine receptors are important modulators of Protein Kinase A (PKA) activity. Dopamine D1 receptors and adenosine A 2A receptors are positively coupled to adenylyl cyclase activity through GS proteins thereby promoting cyclic AMP formation and PKA activation (Arnsten et al. 2005; Fredholm et al. 2005) , which participate in the modulation of hippocampal synaptic plasticity. In a recent study, it has been shown that hyperactivity of both D1 and A 2A receptors in hippocampus leads to increased PKA activity contributing to cognitive dysfunction in Huntington's disease (Tyebji et al. 2015) . It was noted that the concomitant pharmacological exclusion of both D1R and A 2A R may be a therapeutic approach to improve cognitive function in this disease (Tyebji et al. 2015) . However, D1R and A 2A Rs do not form heteromeric complexes in neurons as it has been shown for D2R and A 2A R (Hillion et al. 2002) .
In our case, A 2A receptors seem to permit the D1R-evoked ERK1/2 activation. Since the D1R-evoked NR2B(Tyr1472) phosphorylation is necessary for D1R-mediated ERK1/2 activation (David et al. 2014) , and as we show here, this phosphorylation is under the permissive control of A 2A Rs, we suggest that this could be the molecular mechanism underlying the regulation of D1R-mediated ERK1/2 activation.
Our electrophysiological data showed that the LTP induced in the CA1 field coincides well temporally with an up-regulation of ERK1/2 phosphorylation, detected in the same minislices, 1 h after TBS delivery. It is of interest that the increase in ERK1/2 phosphorylation occurs at 1 h after LTP induction and not at 5 min as shown after direct stimulation of mGluR5 by CHPG administration (Fig. 1) . This indicates that the direct stimulation of the mGluR5 by its agonist has a rapid and transient effect on ERK1/2 activation, while electrical stimulation of a synaptic network leads to a long-lasting activation pattern. However, in line with our biochemical data, the TBS-induced ERK1/2 activation seems to be mGlu5, NMDA, and A 2A receptor dependent, since the application of their antagonists totally prevented the induction of ERK1/2 activation and produced significant reductions in the TBS-induced LTP. This indicates that both phenomena, that is, the induction of LTP and of the ERK1/2 activation are mGlu5, NMDA, and A 2A receptor dependent.
Thus, the electrophysiological data revealed a tight correlation between the induced LTP and the ERK1/2 activation as well as the involvement of A 2A , mGlu5, and NMDA receptors in both phenomena. It is well known that ERK1/2 activation is necessary for the TBS-induced LTP (Selcher et al. 2003; Zhu et al. 2015) . In addition, A 2A R function plays a positive role in the regulation of hippocampal LTP and memory. For example, pharmacological inhibition of A 2A R attenuates LTP in rat hippocampal slices (Rebola et al. 2008; Costenla et al. 2011) . These results confirming our biochemical data point out the role of the tripartite of A 2A R/mGluR5/NMDAR not only in the induction and maintenance of LTP, but also in the TBS-induced stimulation of ERK1/2 signaling pathway.
In conclusion, our results highlight the role of A 2A receptors and the endogenous adenosine in the hippocampus as a crucial 'fine' tuner of glutamate mGluR5 and dopamine D1 receptor-mediated effects on the NMDAR actions and on ERK1/2 activation. Importantly, these actions control/modulate downstream pathways involved in gene transcription, synaptic plasticity and memory consolidation. Also, considering that mGluR5 play an important role in mental disorders, like Fragile X syndrome and schizophrenia (Matosin and Newell 2013; Nickols and Conn 2014) , A 2A R may potentially be a therapeutically pharmacological target for the regulation of the mGluR5-mediated effects in these disorders.
